Scholar Rock (NASDAQ:SRRK) Reaches New 12-Month High – Still a Buy?

Scholar Rock Holding Corporation (NASDAQ:SRRK)’s stock price reached a new 52-week high during mid-day trading on Tuesday . The stock traded as high as $56.54 and last traded at $54.96, with a volume of 2095146 shares. The stock had previously closed at $54.76.

Analysts Set New Price Targets

Several research firms recently commented on SRRK. Truist Financial raised their target price on Scholar Rock from $44.00 to $55.00 and gave the stock a “buy” rating in a research report on Tuesday, March 3rd. Wedbush increased their price objective on Scholar Rock from $56.00 to $58.00 and gave the stock an “outperform” rating in a research note on Wednesday, April 1st. Citigroup lifted their price objective on Scholar Rock from $55.00 to $58.00 and gave the company a “buy” rating in a report on Wednesday, March 4th. Cantor Fitzgerald restated an “overweight” rating on shares of Scholar Rock in a research note on Thursday, June 18th. Finally, BMO Capital Markets upped their target price on shares of Scholar Rock from $50.00 to $70.00 and gave the stock an “outperform” rating in a report on Wednesday, March 4th. Four research analysts have rated the stock with a Strong Buy rating, twelve have given a Buy rating and one has given a Sell rating to the stock. According to data from MarketBeat, Scholar Rock has a consensus rating of “Buy” and an average price target of $56.00.

Scholar Rock Trading Up 0.4%

The company’s 50-day moving average is $47.94 and its 200-day moving average is $46.35. The firm has a market cap of $6.59 billion, a price-to-earnings ratio of -15.31 and a beta of 0.69. The company has a debt-to-equity ratio of 0.71, a quick ratio of 8.64 and a current ratio of 8.64.

Scholar Rock (NASDAQ:SRRK) last posted its quarterly earnings data on Thursday, May 7th. The company reported ($0.83) earnings per share for the quarter, missing the consensus estimate of ($0.82) by ($0.01). During the same period in the previous year, the company posted ($0.67) EPS. On average, research analysts predict that Scholar Rock Holding Corporation will post -3.23 earnings per share for the current year.

Insider Buying and Selling at Scholar Rock

In other Scholar Rock news, COO Keith Woods sold 10,220 shares of the company’s stock in a transaction on Thursday, April 16th. The shares were sold at an average price of $49.57, for a total transaction of $506,605.40. Following the completion of the sale, the chief operating officer owned 620,055 shares in the company, valued at approximately $30,736,126.35. The trade was a 1.62% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Vikas Sinha sold 10,410 shares of the firm’s stock in a transaction on Thursday, April 16th. The stock was sold at an average price of $49.57, for a total value of $516,023.70. Following the completion of the transaction, the chief financial officer owned 619,856 shares in the company, valued at $30,726,261.92. This represents a 1.65% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last ninety days, insiders have sold 63,491 shares of company stock valued at $3,147,249. 13.30% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Scholar Rock

Large investors have recently bought and sold shares of the company. IFP Advisors Inc increased its position in shares of Scholar Rock by 294.1% in the 4th quarter. IFP Advisors Inc now owns 603 shares of the company’s stock valued at $27,000 after buying an additional 450 shares in the last quarter. Caitong International Asset Management Co. Ltd bought a new stake in Scholar Rock in the 4th quarter valued at approximately $30,000. Summit Securities Group LLC acquired a new position in Scholar Rock during the fourth quarter worth $31,000. Ramirez Asset Management Inc. acquired a new position in shares of Scholar Rock during the 3rd quarter worth about $37,000. Finally, EverSource Wealth Advisors LLC boosted its holdings in shares of Scholar Rock by 151.3% in the 4th quarter. EverSource Wealth Advisors LLC now owns 872 shares of the company’s stock valued at $38,000 after buying an additional 525 shares during the last quarter. Institutional investors own 91.08% of the company’s stock.

Scholar Rock Company Profile

Scholar Rock is a clinical-stage biotechnology company focused on the discovery and development of protein therapeutics that selectively target growth factors involved in disease processes. The company’s research platform is designed to modulate endogenous growth factor activation and signaling with high specificity, aiming to restore normal biological function across a range of disorders. Scholar Rock’s approach is distinguished by its emphasis on engineering antibodies and biologics that interact with growth factor precursors or latent complexes rather than the active form, potentially offering improved safety and efficacy profiles.

The company’s lead program, SRK-015 (appercept), is an investigational monoclonal antibody targeting the activation of latent myostatin proproteins and is being evaluated for the treatment of spinal muscular atrophy (SMA).